Neoplasia

Papers
(The H4-Index of Neoplasia is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes1100
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada91
Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells58
Tumor marker-based RecistTM is superior to RECIST as criteria to predict the long-term benefits of targeted therapy in advanced non-small-cell lung cancer with driver gene mutations58
Interdisciplinary care of children with diffuse midline glioma55
Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment48
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene43
The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms41
Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.38
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision36
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma34
Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis33
Cyst fluid metabolites distinguish malignant from benign pancreatic cysts33
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells33
The breast tissue microbiome, stroma, immune cells and breast cancer30
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas29
mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer29
Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models29
In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer28
Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms27
Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis27
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer26
Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair25
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma25
Current state of pediatric neuro-oncology imaging, challenges and future directions25
0.091828107833862